Chris Yun

Michael Trautmann, MD

Michael Trautmann has over 25 years of biopharmaceutical industry experience and has been a consultant since 2012. He studied medicine at the Universities of Goettingen and Marburg, Germany and Geneva, Switzerland. His PostDoc at the Institute of Clinical Biochemistry and Experimental Diabetology at the University of Geneva (under Claes Wollheim and Albert Renold) was supported by the German National Research Fund (DFG). His clinical training in Internal Medicine and Gastroenterology in the Department of Internal Medicine, University Hospital Marburg, Germany (Head: Rudolph Arnold) focused on Diabetes and the Endocrine Gut. 1993-2012 he worked at Eli Lilly in Germany and mostly in global functions in Indianapolis, IN, USA. He was involved in clinical development programs in all stages from preclinical to Phase IV. His involvement included insulin developments (including Lispro insulin), obesity drugs (including leptin), and GLP-1 receptor agonists (including exenatide in the Lilly-Amylin alliance) resulting in 4 global drug approvals and numerous publications. Proven strengths include IND/NDA compilation and management (including EU submissions and Japan), protocol design and development, study report generation. Excellent interpersonal and communication skills with the ability to lead teams to achieve objectives successfully.

 

Click here to see consultant’s profile

Leadership List

Officers

G. Alexander Fleming, MD
Executive Chairman

Thomas Seoh
President and Chief Executive Officer

Stephen Casey, MBA
Chief Operating Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, PhD

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Peter Damsbo, MD

Richard Paul, MD

Rob Walsh, MD

Simon Bruce, MD

Theo Gana, MD, PhD

Todd J. Lorenz, MD

 

Regulatory Affairs

G. Alexander Fleming, MD

Arthur Santora, MD, PhD

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

Christopher Kotsopulos, MS

Doug Muchmore, MD

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Joshua Sharlin, Ph.D

Scot Faulkner, MPA

 

EU Regulatory

Catherine Bernard, Ph.D

Michael Trautmann, MD

 

Clinical Operations/Project Management

Chris Yun

Diane Paul, MS, RN

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lynn Schaich

Susan Manley

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Marijke Adams PharmD, Ph.D

Monalisa Chatterji,Ph.D

Virgil Whitehurst, Ph.D

 

CMC and Clinical Supplies Management

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Rob Walsh, MD

 

QA/QC

Christopher Kotsopulos, MS

Joshua Sharlin, Ph.D

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lynn Schaich

Robert Kaster, RPh., ASQ-CQA

 

Medical Writing/Regulatory Submissions

Dahlia Sperling

Russ Neubauer, Ph.D

Sandor Bernath, PhD, MBA

 

Process & Innovation management

Elizabeth Whalley Buono, BSN, RN, MBA, JD

Scot Faulkner, MPA

 

Business Strategy & Management Support

Stephen Casey, MBA

Lisa Jansa, MBA

Martin Lafontaine

 

Founders

G. Alexander Fleming, MD

Lisa Jansa, MBA